Angela L P Chow1, David C Lye2, Onyebuchi A Arah3. 1. Department of Clinical Epidemiology, Institute of Infectious Disease and Epidemiology, Tan Tock Seng Hospital, Singapore Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, United States Angela_Chow@ttsh.com.sg. 2. Department of Infectious Diseases, Institute of Infectious Disease and Epidemiology, Tan Tock Seng Hospital, Singapore Yong Loo Lin School of Medicine, National University of Singapore, Singapore. 3. Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, United States Center for Health Policy Research, University of California, Los Angeles (UCLA), Los Angeles, United States.
Abstract
OBJECTIVE: Antibiotic computerized decision support systems (CDSSs) were developed to guide antibiotic decisions, yet prescriptions of CDSS-recommended antibiotics have remained low. Our aim was to identify predictors of patients' receipt of empiric antibiotic therapies recommended by a CDSS when the prescribing physician had an initial preference for using broad-spectrum antibiotics. METHODS: We conducted a prospective cohort study in a 1 500-bed tertiary-care hospital in Singapore. We included all patients admitted from October 1, 2011 through September 30, 2012, who were prescribed piperacillin-tazobactam or carbapenem for empiric therapy and auto-triggered to receive antibiotic recommendations by the in-house antibiotic CDSS. Relevant data on the patient, prescribing and attending physicians were collected via electronic linkages of medical records and administrative databases. To account for clustering, we used multilevel logistic regression models to explore factors associated with receipt of CDSS-recommended antibiotic therapy. RESULTS: One-quarter of the 1 886 patients received CDSS-recommended antibiotics. More patients treated for pneumonia (33.2%) than sepsis (12.1%) and urinary tract infections (7.1%) received CDSS-recommended antibiotic therapies. The prescribing physician - but not the attending physician or clinical specialty - accounted for some (13.3%) of the variation. Prior hospitalization (odds ratio [OR] 1.32, 95% CI, 1.01-1.71), presumed pneumonia (OR 6.77, 95% CI, 3.28-13.99), intensive care unit (ICU) admission (OR 0.38, 95% CI, 0.21-0.66), and renal impairment (OR 0.70, 95% CI, 0.52-0.93) were factors associated with patients' receipt of CDSS-recommended antibiotic therapies. CONCLUSIONS: We observed that ICU admission and renal impairment were negative predictors of patients' receipt of CDSS-recommended antibiotic therapies. Patients admitted to ICU and those with renal impairment might have more complex clinical conditions that require a physician's assessment in addition to antibiotic CDSS.
OBJECTIVE: Antibiotic computerized decision support systems (CDSSs) were developed to guide antibiotic decisions, yet prescriptions of CDSS-recommended antibiotics have remained low. Our aim was to identify predictors of patients' receipt of empiric antibiotic therapies recommended by a CDSS when the prescribing physician had an initial preference for using broad-spectrum antibiotics. METHODS: We conducted a prospective cohort study in a 1 500-bed tertiary-care hospital in Singapore. We included all patients admitted from October 1, 2011 through September 30, 2012, who were prescribed piperacillin-tazobactam or carbapenem for empiric therapy and auto-triggered to receive antibiotic recommendations by the in-house antibiotic CDSS. Relevant data on the patient, prescribing and attending physicians were collected via electronic linkages of medical records and administrative databases. To account for clustering, we used multilevel logistic regression models to explore factors associated with receipt of CDSS-recommended antibiotic therapy. RESULTS: One-quarter of the 1 886 patients received CDSS-recommended antibiotics. More patients treated for pneumonia (33.2%) than sepsis (12.1%) and urinary tract infections (7.1%) received CDSS-recommended antibiotic therapies. The prescribing physician - but not the attending physician or clinical specialty - accounted for some (13.3%) of the variation. Prior hospitalization (odds ratio [OR] 1.32, 95% CI, 1.01-1.71), presumed pneumonia (OR 6.77, 95% CI, 3.28-13.99), intensive care unit (ICU) admission (OR 0.38, 95% CI, 0.21-0.66), and renal impairment (OR 0.70, 95% CI, 0.52-0.93) were factors associated with patients' receipt of CDSS-recommended antibiotic therapies. CONCLUSIONS: We observed that ICU admission and renal impairment were negative predictors of patients' receipt of CDSS-recommended antibiotic therapies. Patients admitted to ICU and those with renal impairment might have more complex clinical conditions that require a physician's assessment in addition to antibiotic CDSS.
Authors: Roel Fijn; Man-Chie Chow; Pauline M H Schuur; Lolkje T W De Jong-Van den Berg; Jacobus R B J Brouwers Journal: Pharmacoepidemiol Drug Saf Date: 2002 Jul-Aug Impact factor: 2.890
Authors: Christine B Teng; Winnie Lee; Chay Leng Yeo; Siok Ying Lee; Tat Ming Ng; Siang Fei Yeoh; Wee Heng Lim; Andrea L Kwa; Koh Cheng Thoon; Say Tat Ooi; Thean Yen Tan; Li Yang Hsu; David C Lye; Maciej Piotr Chlebicki Journal: Ann Acad Med Singapore Date: 2012-01 Impact factor: 2.473
Authors: Jessina C McGregor; Elizabeth Weekes; Graeme N Forrest; Harold C Standiford; Eli N Perencevich; Jon P Furuno; Anthony D Harris Journal: J Am Med Inform Assoc Date: 2006-04-18 Impact factor: 4.497
Authors: Annette Moxey; Jane Robertson; David Newby; Isla Hains; Margaret Williamson; Sallie-Anne Pearson Journal: J Am Med Inform Assoc Date: 2010 Jan-Feb Impact factor: 4.497
Authors: E Charani; E Castro-Sanchez; N Sevdalis; Y Kyratsis; L Drumright; N Shah; A Holmes Journal: Clin Infect Dis Date: 2013-04-09 Impact factor: 9.079
Authors: Manuel Rodriguez-Maresca; Antonio Sorlozano; Magnolia Grau; Rocio Rodriguez-Castaño; Andres Ruiz-Valverde; Jose Gutierrez-Fernandez Journal: Biomed Res Int Date: 2014-08-17 Impact factor: 3.411
Authors: Shi Thong Heng; Joshua Wong; Barnaby Young; Hui Lin Tay; Sock Hoon Tan; Min Yi Yap; Christine B Teng; Brenda Ang; Tau Hong Lee; Hui Ling Tan; Thomas W Lew; David Chien Lye; Tat Ming Ng Journal: Open Forum Infect Dis Date: 2020-06-29 Impact factor: 3.835
Authors: Barbara E Jones; Dave S Collingridge; Caroline G Vines; Herman Post; John Holmen; Todd L Allen; Peter Haug; Charlene R Weir; Nathan C Dean Journal: Appl Clin Inform Date: 2019-01-02 Impact factor: 2.342
Authors: Tat Ming Ng; Shi Thong Heng; Boon Hou Chua; Li Wei Ang; Sock Hoon Tan; Hui Lin Tay; Min Yi Yap; Jason Quek; Christine B Teng; Barnaby E Young; Ray Lin; Brenda Ang; Tau Hong Lee; David C Lye Journal: JAMA Netw Open Date: 2022-05-02
Authors: Lok Hang Wong; Evonne Tay; Shi Thong Heng; Huiling Guo; Andrea Lay Hoon Kwa; Tat Ming Ng; Shimin Jasmine Chung; Jyoti Somani; David Chien Boon Lye; Angela Chow Journal: Antibiotics (Basel) Date: 2021-11-24